Zurueck zur Suche

Reporte zur Charge U021995

Verknuepft ueber VAERS_ID mit VAERSDATA, Vax und Symptoms

40Reporte angezeigt
0Todesfaelle
1Hospitalisiert
0Lebensbedrohlich
0Bleibende Schaeden
TN 6 CA 5 FL 4 MI 4 NJ 3 MO 2 WV 2 MA 2 MN 1 NY 1 PA 1 MD 1

VAERS 2374963

MERCK & CO. INC. · PNEUMO (PNEUMOVAX) · Charge u021995

schwer
Staat
FL
Alter
70,0
Geschlecht
F
Eingang
20.07.2022
Impfdatum
16.07.2022
Beginn
17.07.2022
Tage bis Beginn
1,0
Dosis
1
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: ja
Dizziness Injected limb mobility decreased Injection site pain Loss of consciousness

Symptomtext

Pt had severe arm pain (LA) that lasted a couple of days and severely limited mobility, it resolved over time. The couple of days after immunization pt was dizzy and light headed and passed out "a few times". She went to the ER and was released later with all symptoms gone. As of 7/20 pt reports of no problems besides mild arm aches.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Loss of consciousness
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
oxycodone 10
Allergien
sulfa, macrodanton
Vorherige Impfungen
-

VAERS 2391097

MERCK & CO. INC. · PNEUMO (PNEUMOVAX) · Charge U021995

moderat
Staat
MA
Alter
82,0
Geschlecht
F
Eingang
26.07.2022
Impfdatum
23.07.2022
Beginn
23.07.2022
Tage bis Beginn
0,0
Dosis
1
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: nein
Dyspnoea Oxygen saturation decreased

Symptomtext

Systemic: Allergic: Difficulty Breathing-Severe, Additional Details: 911 was called when pt reported trouble breathing. EMT came. Her oxygen level was low. Oxygen was given and her O2 went up to 95 after oxygen. They then took her out to the ambulance to check up on the patient

Weitere VAERSDATA-Felder
Praegender Schweregrund
Dyspnoea
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2151170

MERCK & CO. INC. · PNEUMO (PNEUMOVAX) · Charge U021995

moderat
Staat
NC
Alter
27,0
Geschlecht
F
Eingang
01.03.2022
Impfdatum
22.02.2022
Beginn
23.02.2022
Tage bis Beginn
1,0
Dosis
1
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt
Erythema Induration Pain Paraesthesia Peripheral swelling Skin warm

Symptomtext

27yr old patient with history of T1DM and other comorbidities presented to office for Pneumococcal Polysaccharide 23-Valent (Pneumovax-23) on 2/22. Patient previously received Pneumococcal Conjugate 13-Valent (Prevnar 13) on 12/20/21 with no issues. RN administered Pneumococcal Polysaccharide 23-Valent (Pneumovax-23, LOT # U021995) IM in patient's left deltoid. On 2/23 0845, patient contacted office noting "overnight left arm swelling down to elbow, firmness/warmth to touch and redness". Pain 10/10, treated with ibuprofen and ice. In AM, swelling no mid-arm, pain 5/10 with continued warmth/redness and firmness. Virtual visit on 2/23 in which patient noted tingling on left side of face once overnight however, overal In AM, swelling no mid-arm, pain 5/10 with continued warmth/redness and firmness. Virtual visit on 2/23 in which patient noted tingling on left side of face once overnight however, overall swelling and pain improved. Provider recommended cetirizine (dosing not specified), diphenhydramine 25-50mg Q6H PRN itching, and OTC H2 blocker twice daily until symptoms resolved. No further documentation in chart regarding reaction.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Paraesthesia
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2507317

MERCK & CO. INC. · PNEUMO (PNEUMOVAX) · Charge u021995

mild
Staat
KY
Alter
80,0
Geschlecht
M
Eingang
14.11.2022
Impfdatum
12.11.2022
Beginn
12.11.2022
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
IM / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Injection site erythema Injection site pain Injection site rash Injection site warmth Neck pain Pain Sensitive skin

Symptomtext

2 hours after vaccination had pain shooting from injection site up the neck. Arm was also sensitive to touch, but not sensitive to movement. Upper right arm was warm and red with rash that was larger than just localized to injection site.. Two days after injection, came to pharmacy was advised to seek medical attention. was prescribed Prednisone 10mg 1-2 qd for 7 days.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Injection site erythema
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
Myrbetriq ER 25mg
Allergien
-
Vorherige Impfungen
-

VAERS 2489641

MERCK & CO. INC. · PNEUMO (PNEUMOVAX) · Charge U021995

mild
Staat
NJ
Alter
21,0
Geschlecht
F
Eingang
26.10.2022
Impfdatum
15.09.2022
Beginn
15.09.2022
Tage bis Beginn
0,0
Dosis
1
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Blood test normal Hypoaesthesia Injection site bruising Injection site indentation Injection site pain X-ray normal

Symptomtext

Site: Bruising at Injection Site-Medium, Site: Pain at Injection Site-Severe, Systemic: Numbness (specify: facial area, extremities)-Medium, Additional Details: Patient has pain, severe sensitivity, and tenderness at the injection site. Arm becomes numb during physical activity, like exercise, then becomes sore afterwards. There's a dip/pit in her arm at the injection area which has gotten bigger over time. Her PCP described it as it seems to be "eating away at the muscle & the tissue is disappearing." Her blood work & x-ray came back normal so PCP recommended she see an orthopedic specializing in bone & tissue.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Injection site bruising
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2409880

MERCK & CO. INC. · PNEUMO (PNEUMOVAX) · Charge U021995

mild
Staat
FL
Alter
69,0
Geschlecht
F
Eingang
12.08.2022
Impfdatum
10.08.2022
Beginn
11.08.2022
Tage bis Beginn
1,0
Dosis
1
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Joint swelling Rash Swelling Tenderness

Symptomtext

welling under the left arm down to the elbow, pain to the touch and rash down the left arm through the elbow (underside of the arm)

Weitere VAERSDATA-Felder
Praegender Schweregrund
Rash
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
Multiple Sclerosis
Andere Medikamente
amantadine, simvastatin, metronidazole cream, citracal slow release, vitamin D3, Vitamin C, Fibercon, Fish Oil, Omeprazole, Famotadine, Prolia, Miralax
Allergien
only adhesives and none were applied
Vorherige Impfungen
-

VAERS 2270700

MERCK & CO. INC. · PNEUMO (PNEUMOVAX) · Charge U021995

mild
Staat
FL
Alter
74,0
Geschlecht
F
Eingang
11.05.2022
Impfdatum
06.05.2022
Beginn
06.05.2022
Tage bis Beginn
0,0
Dosis
1
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Asthenia Back pain Confusional state Dizziness Headache Injection site erythema Nausea Pain

Symptomtext

Site: Redness at Injection Site-Mild, Systemic: Body Aches Generalized-Mild, Systemic: Confusion-Mild, Systemic: Dizziness / Lightheadness-Mild, Systemic: pt complained of lower back pain-Mild, Systemic: Headache-Mild, Systemic: Nausea-Mild, Systemic: Weakness-Mild, Additional Details: EMS was called , symptoms seemed to go away after about 20 minutes of injection

Weitere VAERSDATA-Felder
Praegender Schweregrund
Back pain
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2209335

MERCK & CO. INC. · PNEUMO (PNEUMOVAX) · Charge U021995

mild
Staat
MA
Alter
57,0
Geschlecht
F
Eingang
31.03.2022
Impfdatum
22.03.2022
Beginn
22.03.2022
Tage bis Beginn
0,0
Dosis
1
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: nein
Arthralgia Blood test Impaired work ability Sleep disorder X-ray

Symptomtext

about 4 hours after started with pain in shoulder, really severe shoulder pain, no sleeping, took days off work, still going on and is 9 days later. Went to ED and then orthopedics also to eval what happened

Weitere VAERSDATA-Felder
Praegender Schweregrund
Arthralgia
Hospital-Tage
-
Labordaten
xrays, blood work to check for infection
Aktuelle Erkrankungen
none
Vorgeschichte
asthma, allergies, OAB, MVP, PSVT, GERD
Andere Medikamente
Omeprazole, Verapamil, Albuterol, Azelastine, Mometasone, Paroxetine, Cholecalciferol, Cetirizine, Atorvastatin, Fluticasone Propionate, Montelukast, MVI, Vibegron
Allergien
Shellfish, Cat dander, Codeine, Dog Dander, Dust Mite, Sulfamethoxale-trimethoprim
Vorherige Impfungen
-

VAERS 2177764

UNKNOWN MANUFACTURER · VACCINE NOT SPECIFIED (NO BRAND NAME) · Charge U021995

mild
Staat
MO
Alter
33,0
Geschlecht
F
Eingang
14.03.2022
Impfdatum
07.03.2022
Beginn
14.03.2022
Tage bis Beginn
7,0
Dosis
1
Route/Site
IM / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Injection site erythema Joint range of motion decreased Lymphadenopathy Pain in extremity

Symptomtext

right arm pain redness from the injection site down decreased range of motion swollen lymph nodes.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Injection site erythema
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
Allergic rhinitis Anticoagulated on Coumadin Anxiety Asthma Atrioventricular canal (AVC) AV block Chronic TMJ pain Desensitization to allergens DVT (deep venous thrombosis) Environmental allergies History of blood clots History of cardiac anomaly History of DVT (deep vein thrombosis)-right upper extremity-2021 History of herpes genitalis-on PCR 7/21 History of menorrhagia-with history of iron deficieny anemia- Dr. follows-controlled with depo- reviewed Dr. note 10/27/21 History of thrombosis-anterior tibial artery -post thrombectomy-2019 Hx of long term use of blood thinners Iron deficiency anemia Left lower lobe pulmonary infiltrate Mild intermittent asthma without complication Palpitations Raynaud's phenomenon 02/07/2020
Andere Medikamente
Coumadin 4 mg oral tablet (warfarin), Take one 4mg tablet with one 10mg tablet to equal 14mg on Tues, Thurs, Sat, and Sunday. EpiPen Auto-Injector 0.3 mg injectable kit (EPINEPHrine), 0.3 mg, Intramuscular, Once ipratropium 500 mcg/2.5 mL i
Allergien
Mirena Toprol-XL Mucinex ChloraPrep One-Step
Vorherige Impfungen
-

VAERS 2110345

MERCK & CO. INC. · PNEUMO (PNEUMOVAX) · Charge U021995

mild
Staat
SC
Alter
66,0
Geschlecht
M
Eingang
14.02.2022
Impfdatum
08.02.2022
Beginn
09.02.2022
Tage bis Beginn
1,0
Dosis
UNK
Route/Site
IM / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Injection site erythema Injection site infection Injection site swelling Pain

Symptomtext

Pt. described "whole upper arm redness and swelling, painful to move arm, all per pt.'s report" On ~2/12/21, pt. communicated to clinic that he received antibiotic from an urgi care provider for site infection. On 2/14/22, myself and Dr. examined arm: all reported side effects completely resolved, in terms of observation.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Injection site erythema
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
Chronic pain
Vorgeschichte
Thrombocytopenia, GERD, low back pain; MSK pain, PTSD, somatization disorder, hyperlipidemia, allergic rhinitis
Andere Medikamente
========================================================================= 1) ASCORBIC ACID 500MG TAB Qty: 60 for 30 HOLD Issu:01-11-22 days Sig: TAKE TWO TABLETS BY MOUTH Refills: 2 Last:01-12-22 EVERY DAY F
Allergien
Penicillin and penicillin G-related PCNs; haloperidol
Vorherige Impfungen
-

VAERS 2095905

MERCK & CO. INC. · PNEUMO (PNEUMOVAX) · Charge u021995

mild
Staat
DC
Alter
41,0
Geschlecht
M
Eingang
08.02.2022
Impfdatum
04.02.2022
Beginn
05.02.2022
Tage bis Beginn
1,0
Dosis
1
Route/Site
IM / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Feeling abnormal Injection site rash Pyrexia

Symptomtext

The day after (Saturday, 2/5) I had a fever of about 100 for most of the day, and felt generally crappy. The fever was gone by the following morning and hasn?t returned. I also noticed a rash near the injection site on my right shoulder in the morning on Sunday, 2/6. The rash seems to have mostly gone away.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Injection site rash
Hospital-Tage
-
Labordaten
None
Aktuelle Erkrankungen
No
Vorgeschichte
HIV on ART
Andere Medikamente
flaxseed oil 1000 mg PO qday minoxidil topical 5% foam, 1 application topically qday psyllium husk 0.52 gram caps, 2 gram capsules x 5 capsules (10 grams) once per day Triumeq 600-50-300 mg tabs, 1 tab PO qday Vitamin D3 50 mcg (2,000 unit)
Allergien
None
Vorherige Impfungen
-

VAERS 2066845

MERCK & CO. INC. · PNEUMO (PNEUMOVAX) · Charge u021995

mild
Staat
PA
Alter
72,0
Geschlecht
F
Eingang
26.01.2022
Impfdatum
25.01.2022
Beginn
26.01.2022
Tage bis Beginn
1,0
Dosis
1
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Asthenia Confusional state Dizziness Dysstasia Fall Fatigue Nausea Sleep disorder

Symptomtext

The patient received their vaccine on 01/25/22 and felt fine. she went home, felt normal, ate supper, and went to bed. Around 2 am, husband reported to us that the patient felt tired and weak, fell when she stood up, felt dizzy, and nauseous (did not throw up though). After falling, husband helped her to stand back up. She stated that she felt confused, but then had a glass of water and felt better after about 30 minutes. Today when they called to inform us of what happened, she said she now felt much better.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Dizziness
Hospital-Tage
-
Labordaten
none
Aktuelle Erkrankungen
none
Vorgeschichte
n/a
Andere Medikamente
none known
Allergien
quinolones, sulfa, cipro, metronidazole
Vorherige Impfungen
-

VAERS 2066030

MERCK & CO. INC. · PNEUMO (PNEUMOVAX) · Charge U021995

mild
Staat
MD
Alter
24,0
Geschlecht
F
Eingang
26.01.2022
Impfdatum
24.01.2022
Beginn
25.01.2022
Tage bis Beginn
1,0
Dosis
1
Route/Site
SYR / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Injection site erythema Injection site swelling Injection site urticaria Muscle tightness Pain in extremity Peripheral swelling

Symptomtext

My right arm that was injected with the Pneumonia vaccine was increasingly getting sore throughout the first day and by the night it felt sorer than the average soreness I usually feel from vaccines. The second night, alongside the soreness, I noticed red hives at the top of the right inner part of my right arm and hives on the back of my right arm. I took Benadryl that night to see if the hives would go away. The 3rd day (today) the red hives have spread more on the inner top part of my right arm getting closer to my armpit. My right arm is still sore and the muscle feels tight. My arm also appears swollen where the muscle is tight and the hives are. My left arm with the flu vaccine has no unusual events.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Injection site erythema
Hospital-Tage
-
Labordaten
N/A
Aktuelle Erkrankungen
N/A
Vorgeschichte
Ulcerative Colitis
Andere Medikamente
Mesalamine
Allergien
No Allergies
Vorherige Impfungen
-

VAERS 1865550

MERCK & CO. INC. · PNEUMO (PNEUMOVAX) · Charge U021995

mild
Staat
NJ
Alter
67,0
Geschlecht
F
Eingang
12.11.2021
Impfdatum
12.11.2021
Beginn
12.11.2021
Tage bis Beginn
0,0
Dosis
1
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Injection site erythema Injection site pruritus Injection site swelling

Symptomtext

THE PATIENT CALLED THE OFFICE STATING THE VACCINE INJECTION WAS ITCHY, RED, SWOLLEN. SHE ARRIVED AT 3:15 PM. VITAL SIGNS STABLE, NO RESPIRATORY DISTRESS/SYMPTOMS. THE AREA WAS RAISED/SWOLLEN APPROX. ONE HALF INCH HIGH BY TWO INCHES IN DIAMETER. THE PATIENT STATES SHE NEVER HAD A REACTION TO ANY VACCINE IN HER PAST. DR. EVALUATED THE PATIENT. ICE PACK APPLIED, DISCHARGED TO HOME IN STABLE CONDITION.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Injection site erythema
Hospital-Tage
-
Labordaten
NONE
Aktuelle Erkrankungen
NONE
Vorgeschichte
NONE
Andere Medikamente
AMLODIPINE, QUINAPRIL, ROSUVASTATIN
Allergien
NKA
Vorherige Impfungen
-

VAERS 1865100

MERCK & CO. INC. · PNEUMO (PNEUMOVAX) · Charge U021995

mild
Staat
MO
Alter
69,0
Geschlecht
F
Eingang
12.11.2021
Impfdatum
09.11.2021
Beginn
09.11.2021
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Injection site urticaria Lethargy Lymphadenopathy Pyrexia

Symptomtext

Fever, lethargy, swollen lymph nodes beginning evening of 11/9/2021. Pt reports hives on same shoulder as injection site beginning morning after immunization. Treated with ibuprofen and meloxicam. Pt was unable to have scheduled mammogram due to swollen lymph nodes.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Injection site urticaria
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
None
Vorgeschichte
Osteoporosis
Andere Medikamente
None Reported
Allergien
Fluroquinolones (Cipro), Flonase
Vorherige Impfungen
-

VAERS 2591443

MERCK & CO. INC. · PNEUMO (PNEUMOVAX) · Charge u021995

gering
Staat
CA
Alter
-
Geschlecht
U
Eingang
05.04.2023
Impfdatum
03.03.2023
Beginn
03.03.2023
Tage bis Beginn
0,0
Dosis
1
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Expired product administered No adverse event

Symptomtext

No additional AE reported; PNEUMOVAX 23 expired on 1/13/2023 and was administered on 3/3/2023; This spontaneous report was received from a pharmacist and referred to a patient of unknown age and gender. The patient's medical history concurrent conditions and concomitant therapies were not reported. On 03-MAR-2023, the patient was vaccinated pneumococcal vaccine, polyvalent (23-valent) (PNEUMOVAX23) injection, lot #U021995, expiration date: 13-JAN-2023, administered for prophylaxis (strength, anatomical location and route of administration were not provided) (expired product administered).

Weitere VAERSDATA-Felder
Praegender Schweregrund
Expired product administered
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2591443

MERCK & CO. INC. · PNEUMO (PNEUMOVAX) · Charge U021995

gering
Staat
CA
Alter
-
Geschlecht
U
Eingang
05.04.2023
Impfdatum
03.03.2023
Beginn
03.03.2023
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Expired product administered No adverse event

Symptomtext

No additional AE reported; PNEUMOVAX 23 expired on 1/13/2023 and was administered on 3/3/2023; This spontaneous report was received from a pharmacist and referred to a patient of unknown age and gender. The patient's medical history concurrent conditions and concomitant therapies were not reported. On 03-MAR-2023, the patient was vaccinated pneumococcal vaccine, polyvalent (23-valent) (PNEUMOVAX23) injection, lot #U021995, expiration date: 13-JAN-2023, administered for prophylaxis (strength, anatomical location and route of administration were not provided) (expired product administered).

Weitere VAERSDATA-Felder
Praegender Schweregrund
Expired product administered
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2605531

MERCK & CO. INC. · PNEUMO (PNEUMOVAX) · Charge U021995

gering
Staat
NY
Alter
-
Geschlecht
U
Eingang
29.03.2023
Impfdatum
27.02.2023
Beginn
27.02.2023
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Expired product administered No adverse event

Symptomtext

No additional AE reported.; patient was accidently administered an expired dose of PNEUMOVAX 23; This spontaneous report was received from a pharmacist and referred to a patient of unknown age or gender. The patient's medical history, concurrent conditions, concomitant therapies and drug reaction/allergies were not reported. On 27-FEB-2023, the patient was accidently administered an expired dose of pneumococcal vaccine, polyvalent (23-valent) (PNEUMOVAX23) injection, a dosage form, once, lot #U021995, expiration date: 13-JAN-2023, administered for prophylaxis (strength and route of administration were not provided) (expired product administered). The pneumococcal vaccine, polyvalent (23-valent) (PNEUMOVAX23) had no prior temperature excursions. No additional adverse event reported.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Expired product administered
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2602748

MERCK & CO. INC. · PNEUMO (PNEUMOVAX) · Charge U021995

gering
Staat
CA
Alter
-
Geschlecht
U
Eingang
24.03.2023
Impfdatum
03.03.2023
Beginn
03.03.2023
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Expired product administered No adverse event

Symptomtext

No additional AE; PNEUMOVAX 23 expired on 1/13/2023 and was administered on 3/3/2023; This spontaneous report was received from a pharmacist, referring to a patient with unknown age and gender. The patient's concomitant therapy, concurrent condition, medical history and drug reactions/allergies were not reported. On 03-MAR-2023, the patient was vaccinated with an expired dose of pneumococcal vaccine, polyvalent (23-valent) (PNEUMOVAX23) (lot number U021995 has been verified to be a valid lot number, expiration date was reported as 13-JAN-2023, dose, route and anatomical location were not provided) for prophylaxis (expired product administered). No additional adverse event (AE) reported (no adverse event).

Weitere VAERSDATA-Felder
Praegender Schweregrund
Expired product administered
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2591445

MERCK & CO. INC. · PNEUMO (PNEUMOVAX) · Charge u021995

gering
Staat
CA
Alter
59,0
Geschlecht
F
Eingang
03.03.2023
Impfdatum
03.03.2023
Beginn
03.03.2023
Tage bis Beginn
0,0
Dosis
1
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Expired product administered No adverse event

Symptomtext

Patient was just administered an expired vaccine and we noticed it a few minutes ago when entering the information into our system. Patient has not yet reported any adverse events and we will follow up with the manufacturer this week to verify the proper course of action moving forward.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Expired product administered
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2588956

MERCK & CO. INC. · PNEUMO (PNEUMOVAX) · Charge U021995

gering
Staat
NJ
Alter
-
Geschlecht
U
Eingang
01.03.2023
Impfdatum
13.02.2023
Beginn
13.02.2023
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Expired product administered No adverse event

Symptomtext

No additional AE reported; a dose of PNEUMOVAX 23 was administered after the labeled expiration date.; This spontaneous report was received from a nurse, concerning a patient of unknown age and gender. The patient's pertinent medical history, concurrent conditions, previous drug reactions, allergies, and concomitant medications were not provided. On 13-FEB-2023, the patient was vaccinated with pneumococcal vaccine, polyvalent (23-valent) (PNEUMOVAX23) pre-filled syringe, at a dose of 0.5 milliliter, product quantity: 1, lot #U021995, expiration date: 13-JAN-2023 (route of administration and anatomical location were not provided), administered for prophylaxis (expired product administered). No additional adverse event was reported.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Expired product administered
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2585865

MERCK & CO. INC. · PNEUMO (PNEUMOVAX) · Charge U021995

gering
Staat
FL
Alter
75,0
Geschlecht
U
Eingang
23.02.2023
Impfdatum
07.02.2023
Beginn
07.02.2023
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
OT / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Expired product administered

Symptomtext

No reported patient side effects.; expired dose of PNEUMOVAX 23 was administered to a patient on 2/7/23 but expired on 1/13/23.; This spontaneous report was received from a pharmacist and referred to a 75-year-old patient of unknown gender. The patient's medical history, concurrent conditions, concomitant therapies, drug reactions and allergies were not reported. On 07-FEB-2023, the patient was vaccinated with an expired dose of pneumococcal vaccine, polyvalent (23-valent) (PNEUMOVAX23), 0.5 milliliter(mL) injection, 0.5 milliliter, lot #U021995, expiration date: 13-JAN-2023, administered subcutaneously (SQ) for prophylaxis (expired product administered). Pharmacist confirmed that expired vaccine administered had never been stored out of temperature range therefore has never had a temperature excursion. No reported patient side effects. Information regarding revaccination provided to the pharmacist as requested.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Expired product administered
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2570645

MERCK & CO. INC. · PNEUMO (PNEUMOVAX) · Charge u021995

gering
Staat
MI
Alter
69,0
Geschlecht
F
Eingang
30.01.2023
Impfdatum
30.01.2023
Beginn
30.01.2023
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Expired product administered

Symptomtext

The vaccine expired 1-13-2023

Weitere VAERSDATA-Felder
Praegender Schweregrund
Expired product administered
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2569693

MERCK & CO. INC. · PNEUMO (PNEUMOVAX) · Charge U021995

gering
Staat
CA
Alter
-
Geschlecht
U
Eingang
27.01.2023
Impfdatum
20.01.2023
Beginn
20.01.2023
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Expired product administered No adverse event

Symptomtext

No additional AE reported; expired PNEUMOVAX 23 (pfs) was administered to a patient; This spontaneous report has been received from a medical assistant and refers to a patient of unknown age and gender. There was no information regarding the patient's medical history, concurrent conditions and concomitant medications provided. On 20-JAN-2023 (reported also as "today"), the patient was vaccinated with an expired dose of Pneumococcal Vaccine, Polyvalent (23-valent) (PNEUMOVAX 23) injection, lot # U021995 confirmed to be valid with expiration date 13-JAN-2023 (exact dose, route of administration, and anatomical location were not reported), for prophylaxis (expired product administered). The vaccine was stored according to prescribing information through the date of administration. There was no additional adverse event reported.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Expired product administered
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2290665

MERCK & CO. INC. · PNEUMO (PNEUMOVAX) · Charge U021995

gering
Staat
WV
Alter
-
Geschlecht
F
Eingang
29.09.2022
Impfdatum
11.05.2022
Beginn
-
Tage bis Beginn
-
Dosis
1
Route/Site
IM / LL
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Product administered to patient of inappropriate age Wrong product administered

Symptomtext

2 month old infant was given Pneumovax 23 instead of the ordered Prevnar 13; This non-serious spontaneous case was received during the Vaccines Adverse Event Reporting System (VAERS) monitoring on 12-JUL-2022 with the following VAERS Primary ID 2290665-01. The original narrative from the sender is as below: 2 month old infant was given Pneumovax 23 instead of the ordered Prevnar 13. Current illness reported as none.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Wrong product administered
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
Prophylaxis
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2241159

MERCK & CO. INC. · PNEUMO (PNEUMOVAX) · Charge U021995

gering
Staat
MI
Alter
0,2
Geschlecht
F
Eingang
29.09.2022
Impfdatum
16.02.2022
Beginn
19.04.2022
Tage bis Beginn
62,0
Dosis
1
Route/Site
IM / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
No adverse event Product administered to patient of inappropriate age Wrong product administered

Symptomtext

physician ordered Pneumo 23 instead of Prevnar. This was not caught by the medical assistant at the time. We received a call 4/19/22 from the Health Department when patient was brought in for her 4 month shots there. )it was thought that they completed a VAERS at that time) Received call today that they did not complete one. Patient's mother was informed of the error. No reaction or harm to the infant. Staff re-educated on verifying and having another MA double check all vaccines prior to administration

Weitere VAERSDATA-Felder
Praegender Schweregrund
Wrong product administered
Hospital-Tage
-
Labordaten
NA
Aktuelle Erkrankungen
NONE
Vorgeschichte
NONE
Andere Medikamente
NONE
Allergien
NKDA
Vorherige Impfungen
-

VAERS 2241159

MERCK & CO. INC. · PNEUMO (PNEUMOVAX) · Charge U021995

gering
Staat
MI
Alter
0,2
Geschlecht
F
Eingang
29.09.2022
Impfdatum
16.02.2022
Beginn
19.04.2022
Tage bis Beginn
62,0
Dosis
N/A
Route/Site
IM / RL
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
No adverse event Product administered to patient of inappropriate age Wrong product administered

Symptomtext

physician ordered Pneumo 23 instead of Prevnar. This was not caught by the medical assistant at the time. We received a call 4/19/22 from the Health Department when patient was brought in for her 4 month shots there. )it was thought that they completed a VAERS at that time) Received call today that they did not complete one. Patient's mother was informed of the error. No reaction or harm to the infant. Staff re-educated on verifying and having another MA double check all vaccines prior to administration

Weitere VAERSDATA-Felder
Praegender Schweregrund
Wrong product administered
Hospital-Tage
-
Labordaten
NA
Aktuelle Erkrankungen
NONE
Vorgeschichte
NONE
Andere Medikamente
NONE
Allergien
NKDA
Vorherige Impfungen
-

VAERS 2361115

MERCK & CO. INC. · PNEUMO (PNEUMOVAX) · Charge U021995

gering
Staat
-
Alter
63,0
Geschlecht
M
Eingang
07.07.2022
Impfdatum
23.05.2022
Beginn
31.05.2022
Tage bis Beginn
8,0
Dosis
UNK
Route/Site
IM / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt
Inappropriate schedule of product administration

Symptomtext

Patient appeared to be due for pneumococcal vaccine. Ordered the vaccine using the ADULT IMM smartset and not the other Smartset New guidelines state for those who have not previously received any pneumococcal vaccine, CDC recommends you give 1 dose of PCV20. For those who have only received PPSV23, CDC recommends you: May give 1 dose of PCV20. PCV20 dose should be administered at least one year after the most recent PPSV23 vaccination. An additional dose of PPSV23 is not recommended since they already received it.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Inappropriate schedule of product administration
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2355698

MERCK & CO. INC. · PNEUMO (PNEUMOVAX) · Charge U021995

gering
Staat
TN
Alter
-
Geschlecht
U
Eingang
03.07.2022
Impfdatum
14.03.2022
Beginn
14.03.2022
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
No adverse event Product storage error

Symptomtext

No additional AE reported; Caller is a HCP calling to report a TE for PNEUMOVAX 23; This spontaneous report has been received from a nurse, referring to a patient of unknown age and gender. The patient's concurrent conditions, medical history, concomitant medications, previous drug reactions, or allergies were not provided. On 14-MAR-2022, the patient was vaccinated with an improperly stored dose of pneumococcal vaccine, polyvalent (23-valent) (PNEUMOVAX23) (lot number U021995 has been verified to be a valid lot number, expiration date 13-JAN-2023) (strength, dose, frequency, and vaccination scheme were not provided) (product storage error) administered for prophylaxis. The pneumococcal vaccine, polyvalent (23-valent) (PNEUMOVAX23) was stored at a temperature of 0 degree Celsius (C) for a time frame of 24 hours. There was a previous temperature excursion. No additional adverse events were reported. This is one of several reports received from the same reporter.; Sender's Comments: US-009507513-2206USA007094: US-009507513-2206USA006587: US-009507513-2206USA006674: US-009507513-2206USA006670: US-009507513-2206USA006770: US-009507513-2206USA006731: US-009507513-2206USA007090: US-009507513-2206USA007068: US-009507513-2206USA006981: US-009507513-2206USA007045: US-009507513-2206USA006852: US-009507513-2206USA007070: US-009507513-2206USA006952: US-009507513-2206USA007059:

Weitere VAERSDATA-Felder
Praegender Schweregrund
No adverse event
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2355697

MERCK & CO. INC. · PNEUMO (PNEUMOVAX) · Charge U021995

gering
Staat
TN
Alter
-
Geschlecht
U
Eingang
03.07.2022
Impfdatum
02.03.2022
Beginn
02.03.2022
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
No adverse event Product storage error

Symptomtext

No additional AE reported; PNEUMOVAX 23 was administered to the patient after the excursion occured.; This spontaneous report has been received from a registered nurse, concerning to a patient of unknown age and gender. The patient's pertinent medical history, concurrent conditions, previous drug reactions, allergies, and concomitant medications were not provided. On 02-MAR-2022, the patient was vaccinated with pneumococcal vaccine, polyvalent (23-valent) (PNEUMOVAX23) injection, lot number U021995 which was determined to be valid with expiration date 13-JAN-2023, for prophylaxis, after a temperature excursion of 0 degrees Celsius (C) for a time frame of 168 hours (product storage error) (dose, vaccination scheme, and frequency were not provided). Additionally, no previous temperature excursion was reported. No additional adverse events (AE) were reported. This is one of several reports received from the same reporter.; Sender's Comments: US-009507513-2206USA006587: US-009507513-2206USA007090: US-009507513-2206USA007070: US-009507513-2206USA007059: US-009507513-2206USA007045: US-009507513-2206USA006981: US-009507513-2206USA006952: US-009507513-2206USA006852: US-009507513-2206USA006731: US-009507513-2206USA006674: US-009507513-2206USA007068: US-009507513-2206USA007098: US-009507513-2206USA006770: US-009507513-2206USA006432: US-009507513-2206USA006670:

Weitere VAERSDATA-Felder
Praegender Schweregrund
No adverse event
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
Prophylaxis
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2355695

MERCK & CO. INC. · PNEUMO (PNEUMOVAX) · Charge U021995

gering
Staat
TN
Alter
-
Geschlecht
U
Eingang
03.07.2022
Impfdatum
15.03.2022
Beginn
15.03.2022
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
No adverse event Product storage error

Symptomtext

No additional AE reported; PNEUMOVAX 23 was administered to the patient after the excursion occured; This spontaneous report was received from a registered nurse referring to an unknown age and gender patient, whose medical history, concurrent conditions, previous adverse drug reaction, allergies, and concomitant medications were not provided. On 15-MAR-2022, after an excursion took place, the patient was vaccinated with an improperly stored dose of pneumococcal vaccine, polyvalent (23-valent) (PNEUMOVAX23), injection, administered for prophylaxis (lot number: U021995 with an expiration date: 13-JAN-2023 was verified to be a valid lot number; strength, dose, frequency, anatomical injection site, and vaccination scheme were not provided) (product storage error). The dose of pneumococcal vaccine, polyvalent (23-valent) (PNEUMOVAX23) was stored in a temperature of 0 degrees Celsius (C) for 24 hours. It was reported that there was a previous temperature excursion. No adverse events were reported. This is one of several reports received from the same reporter.; Sender's Comments: US-009507513-2206USA006770: US-009507513-2206USA006587:

Weitere VAERSDATA-Felder
Praegender Schweregrund
No adverse event
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
Prophylaxis
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2355691

MERCK & CO. INC. · PNEUMO (PNEUMOVAX) · Charge U021995

gering
Staat
TN
Alter
-
Geschlecht
U
Eingang
03.07.2022
Impfdatum
03.03.2022
Beginn
03.03.2022
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
No adverse event Product storage error

Symptomtext

No additional AE reported; Caller is a HCP calling to report a TE for PNEUMOVAX 23. During the evaluation the customer reported that the PNEUMOVAX 23 was administered to the patient after the excursion occured. Additional AE filed in 02190216, 02190130, 02190106, 02190106, 02; This spontaneous report has been received from a nurse referring a patient of an unknown age and gender. The patient's medical history, concurrent conditions, concomitant medications and previous drugs reactions or allergies. On 03-MAR-2022, the patient was vaccinated with pneumococcal vaccine, polyvalent (23-valent) (PNEUMOVAX23) lot number U021995, expiration date on 13-JAN-2023 for prophylaxis (strength, formulation, dose, frequency, and route of administration were not reported) that underwent a temperature excursion of 0.3 Celsius grades in 24 hours (product storage error). No additional adverse events were reported. The outcome of the event was not reported. ; Sender's Comments: US-009507513-2206USA006770: US-009507513-2206USA006587: US-009507513-2206USA007098: US-009507513-2206USA007068:

Weitere VAERSDATA-Felder
Praegender Schweregrund
No adverse event
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2355688

MERCK & CO. INC. · PNEUMO (PNEUMOVAX) · Charge U021995

gering
Staat
TN
Alter
-
Geschlecht
U
Eingang
03.07.2022
Impfdatum
-
Beginn
01.03.2022
Tage bis Beginn
-
Dosis
UNK
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
No adverse event Product storage error

Symptomtext

No Adverse Event; Patient vaccinated with product incorrectly stored; This spontaneous report was received from a registered nurse and refers to a patient of unknow age or gender. The patient's medical history, concurrent conditions, and concomitant therapies were not reported. On 01-MAR-2022, the vaccine pneumococcal vaccine, polyvalent (23-valent) (PNEUMOVAX23) (lot # U021995, expiration date: 13-JAN-2023) was stored incorrectly for a time frame of 24 hours at a temperature of 0.4?C. There was also a previous temperature excursion. On an unknown date, the patient was vaccinated with pneumococcal vaccine, polyvalent (23-valent) (PNEUMOVAX23) injection (dose regimen details not provided, lot #U021995, and expiration date: 13-JAN-2023) administered for prophylaxis. No adverse event was provided. ; Sender's Comments: US-009507513-2206USA006587: US-009507513-2206USA006770: US-009507513-2206USA007068:

Weitere VAERSDATA-Felder
Praegender Schweregrund
No adverse event
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2334832

MERCK & CO. INC. · PNEUMO (PNEUMOVAX) · Charge U021995

gering
Staat
TN
Alter
-
Geschlecht
U
Eingang
25.06.2022
Impfdatum
13.04.2022
Beginn
13.04.2022
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
No adverse event Product storage error

Symptomtext

No additional adverse event; PNEUMOVAX 23 was administered to the patient after the excursion occured/ temperature 0.3C for 24 hours; This spontaneous report was received from a nurse and refers to a patient of unknown age and gender. There was no information about the patient's concurrent conditions, concomitant therapies or medical history provided. On 13-APR-2022, the patient was vaccinated with pneumococcal vaccine, polyvalent (23-valent) (PNEUMOVAX23) injection, lot #U021995, expiration date: 13-JAN-2023, administered for prophylaxis (strength, and route of administration were not provided). It was reported that on that day, pneumococcal vaccine, polyvalent (23-valent) (PNEUMOVAX23) was administered to the patient after the excursion occurred. Administered dose of vaccine experienced the temperature excursion of 0.3 degrees Celsius for 24 hours (product storage error). Previous temperature excursion was reported as yes. No additional adverse event of product quality complaint were reported.

Weitere VAERSDATA-Felder
Praegender Schweregrund
No adverse event
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2304842

MERCK & CO. INC. · PNEUMO (PNEUMOVAX) · Charge U021995

gering
Staat
WV
Alter
0,2
Geschlecht
F
Eingang
01.06.2022
Impfdatum
-
Beginn
11.05.2022
Tage bis Beginn
-
Dosis
UNK
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
No adverse event Product administered to patient of inappropriate age Wrong product administered

Symptomtext

No additional AE reported; Nurse called to report "vaccine error." She stated 2 month old patient was administered PNEUMOVAX 23.; Patient was intended to receive PREVENAR 13; This spontaneous report has been received from a nurse referring a 9-week-old female patient. The patient's pertinent medical history, previous drugs reactions or allergies and concomitant medications were not reported. On 11-MAY-2022, the patient was vaccinated with pneumococcal vaccine, polyvalent (23-valent)(PNEUMOVAX23) at a dose of 0.5milliliter once, lot number U021995, expiration date: 13-JAN-2023, administered as prophylaxis (route and site of administration were not provided) ; the patient was intended to receive pneumococcal vaccine conj 13v (CRM197) (PREVNAR 13) (product administered to patient of inappropriate age, wrong vaccine administered). No additional adverse event was reported.

Weitere VAERSDATA-Felder
Praegender Schweregrund
No adverse event
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2328597

MERCK & CO. INC. · PNEUMO (PNEUMOVAX) · Charge U021995

gering
Staat
-
Alter
67,0
Geschlecht
M
Eingang
10.05.2022
Impfdatum
08.02.2022
Beginn
09.02.2022
Tage bis Beginn
1,0
Dosis
UNK
Route/Site
IM / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: nein
Unevaluable event

Symptomtext

Narrative:

Weitere VAERSDATA-Felder
Praegender Schweregrund
Unevaluable event
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2223209

MERCK & CO. INC. · PNEUMO (PNEUMOVAX) · Charge U021995

gering
Staat
MN
Alter
56,0
Geschlecht
M
Eingang
08.04.2022
Impfdatum
06.04.2022
Beginn
08.04.2022
Tage bis Beginn
2,0
Dosis
1
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Erythema Skin warm Tenderness

Symptomtext

red, warm and tender to touch or use

Weitere VAERSDATA-Felder
Praegender Schweregrund
Erythema
Hospital-Tage
-
Labordaten
none
Aktuelle Erkrankungen
no
Vorgeschichte
Hypothyroidism HTN Psoriasis
Andere Medikamente
B-12 HCTZ Peg prop eye drops Simvastatin Tretinoin cream Triamcinolone cream
Allergien
NKDA or food
Vorherige Impfungen
-

VAERS 2209189

MERCK & CO. INC. · PNEUMO (PNEUMOVAX) · Charge U021995

gering
Staat
-
Alter
67,0
Geschlecht
F
Eingang
31.03.2022
Impfdatum
20.12.2021
Beginn
21.12.2021
Tage bis Beginn
1,0
Dosis
2
Route/Site
SYR / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: ja Erholt: unbekannt
Unevaluable event

Symptomtext

Patient had ED visit and/or hospitalization within 6 weeks of receiving COVID-19 vaccine.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Unevaluable event
Hospital-Tage
1,0
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2054597

MERCK & CO. INC. · PNEUMO (PNEUMOVAX) · Charge U021995

gering
Staat
MI
Alter
65,0
Geschlecht
M
Eingang
21.01.2022
Impfdatum
20.01.2022
Beginn
20.01.2022
Tage bis Beginn
0,0
Dosis
1
Route/Site
IM / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Extra dose administered

Symptomtext

Duplicate vaccination within the same day

Weitere VAERSDATA-Felder
Praegender Schweregrund
Extra dose administered
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 1973900

MERCK & CO. INC. · PNEUMO (PNEUMOVAX) · Charge U021995

gering
Staat
WA
Alter
-
Geschlecht
U
Eingang
23.12.2021
Impfdatum
02.12.2021
Beginn
02.12.2021
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Product storage error

Symptomtext

no additional adverse effect; Incorrect product storage??; This spontaneous report was received from a medical assist concerning a patient of unknown age. No information about the patient's current condition, medical history or concomitant therapy was reported. On 02-DEC-2021, the pneumococcal vaccine, polyvalent (23-valent) (PNEUMOVAX23) underwent a temperature excursion (product storage error) and was administered (dose and route were not reported; lot # U021995, 13-JAN-2023) as prophylaxis. This vaccine was stored above 9 degree Celsius (8.6 degree Celsius) for 15 minutes. No previous excursion was reported. No additional adverse event was reported.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Product storage error
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-